Aquavit Pharmaceuticals

Research &

AQUAGOLD® fine touch (AQT-001) is a precursor to our patented comprehensive personalized medicine technology platform. Invented as one of output form factors of PITO-001, it is currently utilized by key opinion leaders to deliver drugs or biologics directly into the skin. It provides about 1,200 microinjections per minute.